1. From the Division of Cardiopulmonary Sciences, Kent Institute of Medicine and Health Sciences, University of Kent, and Pfizer Global Research and Development, Sandwich Laboratories, UK, Canterbury, Kent, UK (G.B.); Medical Clinic II, University Hospital Giessen, Giessen, Germany (H.A.G., F.G.); and Pulmonary Vascular Research Institute, Canterbury, Kent, UK.